Special Drug Use Investigation for ZEFIX (Lamivudine) Tablet (HBV Cirrhosis)

Lamivudine and Adefovir Dipivoxil Fixed Dose Combination

NCT01353742 ·Status: COMPLETED ·Phase: PHASE1

Lamivudine and Adefovir to Treat Chronic Hepatitis B

NCT00023309 ·Status: COMPLETED ·Phase: PHASE2

Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia)

NCT00338780 ·Status: COMPLETED ·Phase: PHASE4

A Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis.

NCT00275652 ·Status: COMPLETED ·Phase: PHASE3

Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALT

NCT00230477 ·Status: COMPLETED ·Phase: PHASE4

Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis

NCT00076336 ·Status: COMPLETED ·Phase: PHASE3

A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B Alone

NCT00354653 ·Status: COMPLETED ·Phase: PHASE4

Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease Patients

NCT00823550 ·Status: UNKNOWN ·Phase: PHASE4

Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients

NCT00226447 ·Status: COMPLETED ·Phase: PHASE2

Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV)

NCT00140725 ·Status: COMPLETED ·Phase: PHASE3

Lamivudine Extending Therapy in Chronic Hepatitis B Patients After 3-year of Oral Antiviral Agents

NCT02337127 ·Status: UNKNOWN ·Phase: PHASE4

Safety and Efficacy Study of LB80380 in the Patients With Lamivudine-Refractory Chronic Hepatitis B

NCT00895596 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infection

NCT00362635 ·Status: COMPLETED ·Phase: PHASE3

A Randomized Controlled Trial of Lamivudine in Acute Hepatitis B

NCT00380614 ·Status: COMPLETED ·Phase: PHASE4

A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy

NCT00489151 ·Status: UNKNOWN ·Phase: NA

Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis B

NCT00531167 ·Status: COMPLETED ·Phase: PHASE4

An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment Options

NCT00042393 ·Status: APPROVED_FOR_MARKETING

A Phase IIIb: Long-Term Outcomes for Hepatitis B (HepB) Patients in Some Previous Entecavir (ETV) Trials

NCT01337479 ·Status: COMPLETED

Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis B

NCT00095121 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis B

NCT00877149 ·Status: COMPLETED ·Phase: PHASE4

A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.

NCT00044135 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B Vaccine

NCT04289987 ·Status: COMPLETED ·Phase: PHASE2

Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B Patients

NCT00558493 ·Status: COMPLETED ·Phase: PHASE4

Use of TDF in Patients With Inactive Chronic Hepatitis B Infection

NCT02600117 ·Status: COMPLETED ·Phase: PHASE3

Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot Study

NCT01804387 ·Status: UNKNOWN ·Phase: PHASE4